Radiopharmacy giant Syncor International has cut a new three-year agreement and two-year renewal option with Broadlane, a major provider of supply chain services to the healthcare industry. The agreement, which takes effect immediately, establishes
Radiopharmacy giant Syncor International has cut a new three-year agreement and two-year renewal option with Broadlane, a major provider of supply chain services to the healthcare industry. The agreement, which takes effect immediately, establishes Syncor as the distributor of radiopharmaceuticals, including FDG, to Broadlane’s 572 acute care hospitals and 2335 subacute healthcare facilities. In addition to the sole source agreement, Broadlane will also make available to its members Syncor’s PharmaSeed I-125 brachytherapy seeds.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.